Recreational Psychedelic Users Frequently Encounter Complete Mystical Experiences: Trip Content and Implications for Wellbeing
Using text mining of over 2,000 first‑person trip reports and psychometric data from a large survey (N = 1,424), this mixed‑methods study finds that recreational psychedelic users commonly report complete mystical experiences — incidence varying by drug type and dose — and that such experiences are strongly associated with improved psychological wellbeing.
Abstract
A growing proportion of the population is engaging in recreational psychedelic use. Psychedelics are uniquely capable of reliably occasioning mystical experiences in ordinary humans without contemplative or religious backgrounds. While clinical research has made efforts to characterize psychedelic experiences, comparably little is understood about how humans naturalistically engage with psychedelics. The present study employs a mixed-methods approach to examine the content and implications of psychedelic and mystical experiences, occurring outside of laboratory settings. We use text mining analyses to arrive at a qualitative description of psychedelic experiential content by abstracting from over two-thousand written reports of first-person psychedelic experiences. Following up, we conducted quantitative analyses on psychometric data from a large survey (N = 1424) to reveal associations between psychedelic use practices, complete mystical experiences, and psychological wellbeing. Topic-modelling and sentiment analyses present a bottom-up description of human interactions with psychedelic compounds and the content of such experiences. Psychometric results suggest psychedelic users encounter complete mystical experiences in high proportions, dependent on factors such as drug type and dose-response effects. Furthermore, a salient association was established between diverse metrics of wellbeing and those with complete mystical experiences. Our results paint a new picture of the growing relationships between humans and psychedelic experiences in the real-world use context. Ordinary humans appear to encounter complete mystical experiences via recreational psychedelic use, and such experiences are strongly associated with improved psychological wellbeing.
Research Summary of 'Recreational Psychedelic Users Frequently Encounter Complete Mystical Experiences: Trip Content and Implications for Wellbeing'
Introduction
Psychedelic drugs have re-emerged in Western societies after decades of suppression, and increasing numbers of people are using them recreationally. Earlier research and clinical trials have established that classical psychedelics and some related compounds can reliably occasion mystical-type experiences—operationalised as states combining deeply felt positive mood, transcendence of time and space, ineffability, and noetic or mystical qualities such as unity and ego dissolution. However, most prior characterisations come from clinical settings with carefully controlled set and setting, and comparatively little is known about the phenomenology and psychological correlates of psychedelic experiences occurring naturally in recreational contexts. Tianhong and colleagues set out to describe the content of naturalistic psychedelic experiences and to test whether recreational use commonly produces complete mystical experiences, whether those experiences vary by drug type and dose, and whether complete mystical experiences are associated with psychological wellbeing. To do so they combined data-driven text mining of >2,000 first-person trip reports with psychometric analyses of an online survey (N = 1,424) that measured lifetime psychedelic use, dose estimates, mystical experience intensity (MEQ30), and a broad battery of wellbeing measures. The study is presented as descriptive and associative rather than causal, with hypotheses and analysis plans pre-registered on OSF.
Expert Research Summaries
Go Pro to access AI-powered section-by-section summaries, editorial takes, and the full research toolkit.
Full Text PDF
Full Paper PDF
Create a free account to open full-text PDFs.
Study Details
- Study Typeindividual
- Journal
- Topic
- Author
- APA Citation
Qiu, T. T., & Minda, J. P. (2021). Recreational Psychedelic Users Frequently Encounter Complete Mystical Experiences: Trip Content and Implications for Wellbeing. https://doi.org/10.31234/osf.io/xrbzs
References (23)
Papers cited by this study that are also in Blossom
Aday, J. S., Mitzkovitz, C. M., Bloesch, E. K. et al. · Neuroscience and Biobehavioral Reviews (2020)
Barrett, F. S., Johnson, M. W., Griffiths, R. R. · Journal of Psychopharmacology (2015)
Carbonaro, T. M., Johnson, M. W., Griffiths, R. R. · Psychopharmacology (2020)
Carhart-Harris, R. L., Leech, R., Shanahan, M. et al. · Frontiers in Human Neuroscience (2014)
Carlyle, M., Stevens, T., Fawaz, L. et al. · Journal of Psychopharmacology (2019)
Davis, A. K., Clifton, J. M., Weaver, E. G. et al. · Journal of Psychopharmacology (2020)
Forstmann, M., Yudkin, D. A., Prosser, A. M. B. et al. · PNAS (2020)
Griffiths, R. R., Hurwitz, E. S., Davis, A. K. et al. · PLOS ONE (2019)
Griffiths, R. R., Johnson, M. W., Richards, W. A. et al. · Psychopharmacology (2011)
Hartogsohn, I. · Drug Science Policy and Law (2017)
Show all 23 referencesShow fewer
Holze, F., Vizeli, P., Müller, F. et al. · Neuropsychopharmacology (2019)
Johnson, M. W., Richards, W. A., Griffiths, R. R. · Journal of Psychopharmacology (2008)
Johnson, M. W., Hendricks, P. S., Barrett, F. S. et al. · Pharmacology and Therapeutics (2019)
Jungaberle, H., Thal, S., Zeuch, A. et al. · Neuropharmacology (2018)
Liechti, M. E., Dolder, P. C., Schmid, Y. · Psychopharmacology (2016)
Liechti, M. E., Gamma, A., Vollenweider, F. X. · Psychopharmacology (2001)
MacLean, K. A., Leoutsakos, J. S., Johnson, M. W. et al. · Journal for the Scientific Study of Religion (2012)
Pallavicini, C., Cavanna, F., Zamberlan, F. et al. · Journal of Psychopharmacology (2021)
Schmid, Y., Gasser, P., Oehen, P. et al. · Journal of Psychopharmacology (2020)
Strassman, R. J., Qualls, C .R. · JAMA Psychiatry (1994)
Sweat, N. W., Bates, L. W., Hendricks, P. S. · Journal of Psychoactive Drugs (2016)
Timmermann, C., Roseman, L., Williams, L. et al. · Frontiers in Psychology (2018)
Yaden, D. B., Le Nguyen, K. D., Kern, M. L. et al. · Journal of Humanistic Psychology (2016)
Cited By (2)
Papers in Blossom that reference this study
Shinozuka, K., Jerotic, K., Mediano, P. A. M. et al. · Translational Psychiatry (2024)
Sanz, C., Cavanna, F., Muller, S. et al. · Psychopharmacology (2022)
Your Personal Research Library
Go Pro to save papers, add notes, rate studies, and organize your research into custom shelves.